215 related articles for article (PubMed ID: 21173714)
21. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?
Wei S; Asamura H; Kawachi R; Sakurai H; Watanabe S
J Thorac Oncol; 2011 Feb; 6(2):310-8. PubMed ID: 21206387
[TBL] [Abstract][Full Text] [Related]
22. Can a thoracic surgeon identify lymph node metastases during surgery based on their size? Analysis of 844 metastatic and 10,462 nonmetastatic lymph nodes.
Suemitsu R; Takeo S; Matsuzawa H; Yamaguchi M; Momosaki S; Uesugi N
J Thorac Oncol; 2010 Mar; 5(3):349-53. PubMed ID: 20009772
[TBL] [Abstract][Full Text] [Related]
23. Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer.
Kim HK; Choi YS; Kim K; Shim YM; Jeong SY; Lee KS; Kwon OJ; Kim J
J Thorac Oncol; 2009 Oct; 4(10):1242-6. PubMed ID: 19687762
[TBL] [Abstract][Full Text] [Related]
24. Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer.
De Leyn P; Vansteenkiste J; Lievens Y; Van Raemdonck D; Nafteux P; Decker G; Coosemans W; Decaluwé H; Moons J; Lerut T
J Thorac Oncol; 2009 Jan; 4(1):62-8. PubMed ID: 19096308
[TBL] [Abstract][Full Text] [Related]
25. How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems.
Pepek JM; Chino JP; Marks LB; D'amico TA; Yoo DS; Onaitis MW; Ready NE; Hubbs JL; Boyd J; Kelsey CR
J Thorac Oncol; 2011 Apr; 6(4):757-61. PubMed ID: 21325975
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of computed tomography morphologic characteristics in stage I non-small-cell lung cancer.
Meniga IN; Tiljak MK; Ivankovic D; Aleric I; Zekan M; Hrabac P; Mazuranic I; Puljic I
Clin Lung Cancer; 2010 Mar; 11(2):98-104. PubMed ID: 20199975
[TBL] [Abstract][Full Text] [Related]
27. Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial.
Liptay MJ; D'amico TA; Nwogu C; Demmy TL; Wang XF; Gu L; Litle VR; Swanson SJ; Kohman LJ;
J Thorac Oncol; 2009 Feb; 4(2):198-202. PubMed ID: 19179896
[TBL] [Abstract][Full Text] [Related]
28. Patterns of Distant Metastases After Surgical Management of Non-Small-cell Lung Cancer.
Torok JA; Gu L; Tandberg DJ; Wang X; Harpole DH; Kelsey CR; Salama JK
Clin Lung Cancer; 2017 Jan; 18(1):e57-e70. PubMed ID: 27477488
[TBL] [Abstract][Full Text] [Related]
29. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.
Thibault I; Poon I; Yeung L; Erler D; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):713-9. PubMed ID: 25085765
[TBL] [Abstract][Full Text] [Related]
31. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?
Ruffini E; Asioli S; Filosso PL; Buffoni L; Bruna MC; Mossetti C; Solidoro P; Oliaro A
J Thorac Oncol; 2011 Feb; 6(2):319-26. PubMed ID: 21164365
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine.
Collaud S; Waddell TK; Yasufuku K; Pierre AF; Darling GE; Cypel M; Rampersaud YR; Lewis SJ; Shepherd FA; Leighl NB; Cho J; Bezjak A; Tsao MS; Keshavjee S; de Perrot M
J Thorac Oncol; 2013 Dec; 8(12):1538-44. PubMed ID: 24389435
[TBL] [Abstract][Full Text] [Related]
33. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
Sakurai H; Asamura H; Goya T; Eguchi K; Nakanishi Y; Sawabata N; Okumura M; Miyaoka E; Fujii Y;
J Thorac Oncol; 2010 Oct; 5(10):1594-601. PubMed ID: 20736855
[TBL] [Abstract][Full Text] [Related]
34. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
[TBL] [Abstract][Full Text] [Related]
35. Management of ipsilateral intrapulmonary metastases in the new TNM system for non-small cell lung cancer.
Kamiyoshihara M; Kawashima O; Sakata S; Hirai T; Ishikawa S; Morishita Y
J Cardiovasc Surg (Torino); 2000 Dec; 41(6):931-4. PubMed ID: 11232979
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic features in resected subcentimeter lung cancer--status of lymph node metastases.
Zhou Q; Suzuki K; Anami Y; Oh S; Takamochi K
Interact Cardiovasc Thorac Surg; 2010 Jan; 10(1):53-7. PubMed ID: 19833638
[TBL] [Abstract][Full Text] [Related]
37. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.
Robinson BM; Kennedy C; McLean J; McCaughan BC
J Thorac Oncol; 2011 Oct; 6(10):1691-6. PubMed ID: 21869717
[TBL] [Abstract][Full Text] [Related]
38. Completion pneumonectomy in patients with cancer: postoperative survival and mortality factors.
Tabutin M; Couraud S; Guibert B; Mulsant P; Souquet PJ; Tronc F
J Thorac Oncol; 2012 Oct; 7(10):1556-62. PubMed ID: 22982656
[TBL] [Abstract][Full Text] [Related]
39. Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with non-small cell lung cancer in non-operable patients pursuing radiotherapy as a primary treatment.
Nakajima T; Yasufuku K; Nakajima M; Baba M; Yoshikawa K; Kamada T; Hiroshima K; Nakatani Y; Fujisawa T; Yoshino I
J Thorac Oncol; 2010 May; 5(5):606-11. PubMed ID: 20354458
[TBL] [Abstract][Full Text] [Related]
40. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]